These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 31239387

  • 1. Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic Escherichia coli Infection.
    Eichler T, Bender K, Murtha MJ, Schwartz L, Metheny J, Solden L, Jaggers RM, Bailey MT, Gupta S, Mosquera C, Ching C, La Perle K, Li B, Becknell B, Spencer JD.
    J Am Soc Nephrol; 2019 Aug; 30(8):1385-1397. PubMed ID: 31239387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human Ribonuclease 6 Has a Protective Role during Experimental Urinary Tract Infection.
    Ruiz-Rosado JD, Cortado H, Kercsmar M, Li B, Ballash G, Cotzomi-Ortega I, Sanchez-Zamora YI, Gupta S, Ching C, Boix E, Jackson AR, Spencer JD, Becknell B.
    J Innate Immun; 2023 Aug; 15(1):865-875. PubMed ID: 37980892
    [Abstract] [Full Text] [Related]

  • 6. An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract.
    Spencer JD, Schwaderer AL, Eichler T, Wang H, Kline J, Justice SS, Cohen DM, Hains DS.
    Kidney Int; 2014 May; 85(5):1179-91. PubMed ID: 24107847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
    Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V.
    PLoS Pathog; 2015 Apr; 11(4):e1004818. PubMed ID: 25927232
    [Abstract] [Full Text] [Related]

  • 9. Uropathogenic Escherichia coli infection: innate immune disorder, bladder damage, and Tailin Fang II.
    Li ZP, Li J, Li TL, Song ZY, Gong XZ.
    Front Cell Infect Microbiol; 2024 Apr; 14():1322119. PubMed ID: 38638825
    [Abstract] [Full Text] [Related]

  • 10. A non-canonical autophagy-dependent role of the ATG16L1T300A variant in urothelial vesicular trafficking and uropathogenic Escherichia coli persistence.
    Wang C, Bauckman KA, Ross ASB, Symington JW, Ligon MM, Scholtes G, Kumar A, Chang HW, Twentyman J, Fashemi BE, Xavier RJ, Mysorekar IU.
    Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Murine Ribonuclease 6 Limits Bacterial Dissemination during Experimental Urinary Tract Infection.
    Cortado H, Kercsmar M, Li B, Vasquez-Martinez G, Gupta S, Ching C, Ballash G, Cotzomi-Ortega I, Sanchez-Zamora YI, Boix E, Zepeda-Orozco D, Jackson AR, Spencer JD, Ruiz-Rosado JD, Becknell B.
    J Innate Immun; 2024 Mar; 16(1):283-294. PubMed ID: 38744252
    [Abstract] [Full Text] [Related]

  • 13. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y, Nishitani C, Ariki S, Saito A, Hasegawa Y, Takahashi M, Hashimoto J, Takahashi S, Tsukamoto T, Kuroki Y.
    J Biol Chem; 2012 Nov 16; 287(47):39578-88. PubMed ID: 23012359
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HL.
    mBio; 2012 Nov 16; 3(1):. PubMed ID: 22318320
    [Abstract] [Full Text] [Related]

  • 15. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic Escherichia coli bladder epithelial cell invasion in vitro.
    Sawant NV, Chang SS, Pandit KA, Khekare P, Warner WR, Zimmern PE, De Nisco NJ.
    Microbiol Spectr; 2024 Mar 05; 12(3):e0271223. PubMed ID: 38240572
    [Abstract] [Full Text] [Related]

  • 16. Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection.
    Schwartz L, Salamon K, Simoni A, Eichler T, Jackson AR, Murtha M, Becknell B, Kauffman A, Linn-Peirano S, Holdsworth N, Tyagi V, Tang H, Rust S, Cortado H, Zabbarova I, Kanai A, Spencer JD.
    Cell Rep; 2024 Apr 23; 43(4):114007. PubMed ID: 38517889
    [Abstract] [Full Text] [Related]

  • 17. Uropathogenic Escherichia coli preferentially utilize metabolites in urine for nucleotide biosynthesis through salvage pathways.
    Ma J, Cai X, Bao Y, Yao H, Li G.
    Int J Med Microbiol; 2018 Dec 23; 308(8):990-999. PubMed ID: 30145133
    [Abstract] [Full Text] [Related]

  • 18. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES, Hunstad DA.
    J Infect Dis; 2015 Apr 01; 211(7):1164-73. PubMed ID: 25336727
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D, Sullivan MJ, Duell BL, Goh KGK, Katupitiya L, Gosling D, Chamoun MN, Kakkanat A, Chattopadhyay D, Crowley M, Crossman DK, Schembri MA, Ulett GC.
    mSphere; 2019 Nov 27; 4(6):. PubMed ID: 31776239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.